Source: Nature
Researchers have demonstrated that consumer smartwatches can identify hypertension indicators through opportunistic monitoring—meaning the device flags risk during routine daily use rather than requiring deliberate clinical testing. This addresses a gap in preventive health: since hypertension is asymptomatic and affects nearly 1.3 billion people globally, detection on devices billions already wear could move diagnosis from clinical settings to everyday life. Validation across diverse populations and integration into clinical workflows remain unsettled.